Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
IsoRay Inc is a medical devices business based in the US. IsoRay shares (ISR) are listed on the NYSE MKT and all prices are listed in US Dollars. IsoRay employs 61 staff and has a trailing 12-month revenue of around $11 million.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Social traders
| Latest market close | $0.22 |
|---|---|
| 52-week range | $0.25 - $0.69 |
| 50-day moving average | $0.35 |
| 200-day moving average | $0.35 |
| Wall St. target price | $1.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.04 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.22 from 2022-09-29
| 1 week (2022-09-23) | -21.43% |
|---|---|
| 1 month (2022-08-30) | -39.13% |
| 3 months (2022-06-30) | -29.03% |
| 6 months (2022-03-28) | -40.56% |
| 1 year (2021-09-30) | -65.13% |
|---|---|
| 2 years (2020-09-30) | -62.26% |
| 3 years (2019-09-30) | 0.3207 |
| 5 years (2017-09-29) | 0.5165 |
| Revenue TTM | $11 million |
|---|---|
| Gross profit TTM | $5.1 million |
| Return on assets TTM | -5.8% |
| Return on equity TTM | -9.53% |
| Profit margin | -56.86% |
| Book value | $0.45 |
| Market capitalisation | $40.5 million |
TTM: trailing 12 months
We're not expecting IsoRay to pay a dividend over the next 12 months.
IsoRay's shares were split on a 1:30 basis on 16 August 2005. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your IsoRay shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for IsoRay shares which in turn could have impacted IsoRay's share price.
Over the last 12 months, IsoRay's shares have ranged in value from as little as $0.25 up to $0.69. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while IsoRay's is 0.8706. This would suggest that IsoRay's shares are less volatile than average (for this exchange).
Isoray, Inc. , through its subsidiary, IsoRay Medical, Inc. , develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.